Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

A phase 3 trial involving nearly 25,000 older adults across 17 countries found that a single dose of the RSVPreF3 OA vaccine ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

The need for more organ and tissue donors impacts thousands nationwide, including hundreds in Delaware. These are just a few Delaware stories.

Gold dust in eyes might seem like an unusual therapy – but a new mouse study in the US shows the approach could potentially ...

In a world with too much noise and too little context, Vox helps you make sense of the news. We don’t flood you with ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

As measles cases continue to increase in the United States, this is what you should know about symptoms and your MMR vaccine ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the virus that causes COVID-19 and potentially other coronaviruses that could ...

This contract marks the first official step in the full-scale operation of the ADC manufacturing facility at the Syracuse Bio ...

Roivant Sciences secures $5.2B for advancing late-stage drugs like IMVT-1402 & brepocitinib. Click here to read an analysis ...

New seasonal allergies in adulthood can result from a genetic predisposition, exposure to new allergens, changes to your ...